SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD.

The current price of 688366 is 92.62 CNY — it has decreased by 0.37% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. stocks are traded under the ticker 688366.

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.

688366 stock is 1.82% volatile and has beta coefficient of 1.22. Check out the list of the most volatile stocks — is SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. there?

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. revenue for the last quarter amounts to ‪702.00 M‬ CNY despite the estimated figure of ‪670.00 M‬ CNY. In the next quarter revenue is expected to reach ‪672.00 M‬ CNY.

Yes, you can track SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. financials in yearly and quarterly reports right on TradingView.

688366 stock has fallen by 0.43% compared to the previous week, the month change is a 12.79% fall, over the last year SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. has showed a 4.49% decrease.

688366 net income for the last quarter is ‪89.32 M‬ CNY, while the quarter before that showed ‪121.57 M‬ CNY of net income which accounts for −26.53% change. Track more SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. financial stats to get the full picture.

Yes, 688366 dividends are paid annually. The last dividend per share was 0.40 CNY. As of today, Dividend Yield (TTM)% is 0.43%. Tracking SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. dividends might help you take more informed decisions.

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. dividend yield was 0.84% in 2023, and payout ratio reached 37.09%. The year before the numbers were 0.39% and 36.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 688366 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. stock right from TradingView charts — choose your broker and connect to your account.

688366 reached its all-time high on Jul 14, 2021 with the price of 282.00 CNY, and its all-time low was 60.86 CNY and was reached on Oct 12, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has ‪2.16 K‬ employees. See our rating of the largest employees — is SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. stock shows the strong sell signal. See more of SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. future price: according to them, 688366 price has a max estimate of 115.00 CNY and a min estimate of 95.73 CNY. Read a more detailed SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. forecast: see what analysts think of SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. EBITDA is ‪597.17 M‬ CNY, and current EBITDA margin is 22.63%. See more stats in SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. financial statements.